The Endocrine Society has named Zeynep Madak-Erdogan, Ph.D., of the University of Illinois Urbana-Champaign in Urbana, Ill., as Editor-in-Chief of the Journal of the Endocrine Society (JES). Ashley Grossman M.D., F.R.C.P., of Barts and the London School of Medicine in London, U.K., was also named as the next Editor-in-Chief of Endocrine Reviews
“This is a very exciting time for our Society as we introduce two new Editors-in-Chief who are more than qualified to carry our journals forward in impact and growth,” said Endocrine Society President Carol Wysham, M.D., of the Rockwood/MultiCare Health Systems in Spokane, Wash. “Drs. Grossman and Madak-Erdogan both have extensive journal experience and have brought forward great energy and creative ideas for advancing our journals.”
Madak-Erdogan is a member of the Cancer Center at Illinois, Director of the Women’s Health and Metabolism lab, and founding member of the Cancer Research Advocacy Group at the U of I. Her lab focuses on understanding how hormones and metabolism affect women’s health. Her research centers around using animal and 3D-engineered models, with advanced statistical and computational analysis, to understand how nutrients, environmental toxicant exposures, and hormones impact metabolic health and hormone-dependent cancer outcomes.
“As Editor-in-Chief, I will advance JES’ reputation as an open-access publication and maintain the journal’s scientific and literary quality,” said Madak-Erdogan. “We will reach even more clinicians and basic scientists worldwide with the journal’s innovative research in all areas of endocrinology.”
Journal of the Endocrine Society is an Open Access journal providing rapid publication of clinical research, clinical practice information, and basic research in all areas of endocrinology. Mini-reviews, commentaries, perspectives, case reports, and articles about images, databases, and methods are also featured. Articles undergo a streamlined peer review and are provided with article-level metrics.
Grossman is an Emeritus Professor of Endocrinology at the University of Oxford and Professor of Neuroendocrinology at the University of London in the U.K. who has trained many leading endocrinologists. He won a 2020 Laureate Award from the Society for his outstanding mentorship. His research focus is the pathogenesis of endocrine tumors, including adrenal, pituitary, and neuroendocrine tumors.
“My vision for Endocrine Reviews is for all articles to reflect the most exciting and novel aspects of basic medical science and to be intertwined with their impact on clinical medicine and patient care,” said Grossman. “The fusion of basic knowledge with an understanding of its clinical relevance is one of the most intriguing and challenging areas of medicine. Endocrine Reviews is ideally situated to respond to that challenge and be in the forefront of translational medicine.”
Endocrine Reviews publishes bimonthly, including concise timely reviews updating key mechanistic and clinical concepts, as well as more comprehensive, authoritative review articles spanning both experimental and clinical endocrinology themes. Endocrine Reviews considers topics that inform clinical practice based on emerging and established evidence from clinical research as well as reviews of advances in endocrine science emanating from studies of cell biology, immunology, pharmacology, genetics, molecular biology, neuroscience, reproductive medicine, and pediatric endocrinology.
Grossman and Madak-Erdogan will each serve three-year terms starting January 1, 2022.